Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Nomination Criteria

The Secretary of the Department of Health and Human Services (HHS) appoints members to the Clinical Laboratory Improvement Advisory Committee (CLIAC) based on candidates’ qualifications that enable them to contribute to accomplishing CLIAC’s objectives stated in the Committee Charter. The Federal Advisory Committee Act stipulates that committee membership be balanced in terms of professional training and background, points of view represented, and the committee’s function. Consideration is given on the basis of geographic, ethnic and gender representation (see below). Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees, requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for CLIAC membership each fall, and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in July, or as soon as the HHS selection process is completed. Note that the need for different expertise and individuals to maintain the appropriate demographic balance varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year.

Time and Travel Commitment

  • Four-year terms, starting in July (or as approved by HHS)
  • At least one meeting per year in Atlanta, generally two meetings are held annually
  • Upcoming meeting dates are available on the CLIAC Homepage. Note that dates are subject to change and delays in member approval by HHS could affect the actual term served
  • Travel costs and meals are reimbursed at government rates; a small stipend is provided

Desired Clinical Expertise and Perspectives

Members are selected from authorities knowledgeable in the clinical and anatomic laboratory fields of:

  • Microbiology (including bacteriology, mycobacteriology, mycology, parasitology and virology)
  • Immunology (including histocompatibility)
  • Chemistry
  • Hematology
  • Pathology (including histopathology and cytology)
  • Genetic Testing (including cytogenetics)
  • Immunohematology

Member diversity is also sought in terms of the following qualifications and perspectives:

  • Medical Technology/Clinical Laboratory Science
  • Clinical Practice
  • Public Health
  • Consumers

Submission of Candidate Information

Interested candidates, or the person/organization recommending a candidate, should submit the following items:

  • Current curriculum vitae, including complete contact information and credentials (telephone numbers, mailing address, e-mail address)
  • Optional: Letter(s) of recommendation from person(s) not employed by the U.S. Department of Health and Human Services

Candidate suggestions may be submitted by:

Attention: CLIAC Secretariat 1600 Clifton Road NE Mailstop F-11 Atlanta, GA 30333

The deadline for receipt of materials to be considered for the next term is September 15 of each year. If you have any questions regarding these procedures, please contact CDC’s CLIA phone number 404-498-2290, or send your email inquiry to

CLIAC Member Geographic and Demographic Distribution


1General Administration Manual Chapter 9 (GAM-9)9-00-70, Nomination, Selection and Appointment of Federal Advisory Committee Members:

2Candidates may submit letter(s) from current HHS employees if they wish, but it is suggested that at least one letter be submitted by a person not employed by HHS or its agencies (e.g., CDC, CMS, FDA).